VERITY (Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics) is a NIAMS-funded P30 research program awarded to Brigham and Women’s Hospital. The course is aimed at clinical investigators pursuing rheumatic disease epidemiologic and patient-oriented research. Course attendees will consist of early-stage (typically residents, fellows, or junior faculty) investigators pursuing clinical/patient-oriented/epidemiologic research studies in rheumatic and musculoskeletal diseases. Attendees will develop or refine a research protocol or specific aims for a grant proposal during the course. Tuition is free but travel and lodging should be funded by the applicant’s program.
Through a partnership with Brigham and Women’s Hospital and Harvard Medical School, CARRA is able to select one member to receive travel support and participate in the VERITY/Brigham Course in Rheumatology Clinical Research in Boston, MA at Brigham and Women’s Hospital.
The chosen applicant will have their hotel paid for directly by the course organizers and reimbursement of travel expenses to participate in the 4 day course. Course organizers will coordinate travel arrangements with the chosen applicant. Funding for this travel support is provided by NIAMS.
To be eligible for the CARRA opening you must have renewed your CARRA membership and meet the VERITY/Brigham Course in Clinical Research eligibility guidelines:
The course is directed by Dr. Jeffrey Sparks and Dr. Daniel Solomon of Brigham and Women’s Hospital. To learn more about the 2022 VERITY course, including application materials, deadlines, please visit https://www.verityresearch.org/verity-course-2022/ or email [email protected].
For questions about CARRA’s selection process for this program, contact [email protected]